Bacterial Profile of Respiratory Isolates in a Tertiary Care Teaching Hospital in Central India: A Retrospective Laboratory-Based Study

Main Article Content

Dr. Kamlesh Patel
Dr. Mukesh Bansal
Dr. Neeraj Katare

Abstract

Background: Respiratory specimens submitted for bacterial culture may yield a diverse range of organisms, and the distribution of recovered isolates varies with patient population, specimen type, clinical setting, and local epidemiology. Interpretation requires attention to specimen quality and the possibility of airway colonization, particularly in patients with artificial airways [1–3].


Objective: To describe the distribution of clinically significant bacterial isolates recovered from respiratory specimens in a tertiary care teaching hospital in Central India.


Methods: This retrospective laboratory-based observational study reviewed respiratory culture records from the Department of Microbiology, Sri Aurobindo Medical College and Postgraduate Institute, Indore, Madhya Pradesh, India. The source manuscript specifies January–December 2025; this period and the final eligible denominator must be verified against the laboratory export. Identification was based on standard microbiological procedureas and an automated identification system where used. Organism frequencies were summarized descriptively. Antimicrobial susceptibility results were not analysed in this version.


Results: The source records report 746 respiratory isolates. The most frequently listed organisms were Pseudomonas aeruginosa (128), Acinetobacter baumannii complex (122), Escherichia coli (104), Klebsiella pneumoniae (103), and Klebsiella pneumoniae subsp. pneumoniae (95). Pseudomonas putida (25) and Enterobacter cloacae complex (24) were also listed. Candida albicans (34) appeared in the source table but is a fungus and should be excluded from the bacterial denominator or reported separately. The two Klebsiella categories may overlap and require reconciliation. Exact specimen-wise counts and the complete list of remaining organisms were not supplied.


Conclusion: A retrospective review of respiratory culture records can describe organisms recovered in routine diagnostic practice. Before prevalence estimates are reported, the dataset should be checked for the correct denominator, duplicate records, taxonomic overlap, non-bacterial isolates, and missing organism and specimen counts. This analysis describes bacterial distribution only and does not assess antimicrobial resistance or support empirical antibiotic recommendations.


 

Downloads

Download data is not yet available.

References

Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gonzalez MD, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024; ciae104. doi:10.1093/cid/ciae104.

Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-e111.

Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2013;57(4):e22-e121.

Jeyaraman UD, Jagadeesan P, Sundaram V, Rebba V. Characterization and antimicrobial susceptibility pattern of non-fermenting Gram-negative bacilli and molecular analysis of Pseudomonas species from respiratory samples of intensive care unit patients in a tertiary care hospital. J Pure Appl Microbiol. 2023;17(4):2179-2187. doi:10.22207/JPAM.17.4.14.

Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538-582. doi:10.1128/CMR.00058-07.

Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018;7:212527. doi:10.7573/dic.212527.

Indian Council of Medical Research. Annual report: Antimicrobial Resistance Surveillance and Research Network (January–December 2024). New Delhi: ICMR; 2025. Verify the report's final bibliographic details before submission.

Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data. 5th ed. CLSI guideline M39.

Wayne (PA): Clinical and Laboratory Standards Institute; 2022. (Background guidance only; no antibiogram is presented in this manuscript.)

Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI supplement M100. Wayne (PA): Clinical and Laboratory Standards Institute; 2025. (Not used to interpret results in this manuscript.)

World Health Organization. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015.

World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2024. Geneva: World Health Organization; 2024.

World Health Organization. WHO bacterial priority pathogens list, 2024.

Geneva: World Health Organization; 2024.

Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-655. doi:10.1016/S0140-6736(21)02724-0.

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions. Clin Microbiol Infect. 2012;18(3):268-281. doi:10.1111/j.1469-0691.2011.03570.x.

Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079-1081. doi:10.1086/533452.

Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277-283.

Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309-318. doi:10.1179/2047773215Y.0000000030.

Gandra S, Alvarez-Uria G, Turner P, Joshi J, Laxminarayan R. Antimicrobial resistance surveillance in low- and middle-income countries. Clin Microbiol Rev. 2020;33(3):e00048-19. doi:10.1128/CMR.00048-19.

Karuna T, Gupta A, Vyas A, Kumar S, Sampath A, Goel P, et al. Changing trends in antimicrobial susceptibility patterns of bloodstream infection (BSI) in secondary care hospitals of India. Cureus. 2023;15(4):e37800.

doi:10.7759/cureus.37800. (Related regional surveillance context; not respiratory-specific.)

World Health Organization. WHO guidelines on hand hygiene in health care. Geneva: World Health Organization; 2009.

Article Details

Section

Articles

How to Cite

Bacterial Profile of Respiratory Isolates in a Tertiary Care Teaching Hospital in Central India: A Retrospective Laboratory-Based Study . (2026). ACE Journal of Addiction, 7(1), 64-69. https://doi.org/10.61705/8jcbn261